The Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents have been updated!
Revisions are largely based on findings from two large, randomized controlled trials that addressed the optimal time to initiate ART -- START and TEMPRANO.
Please send any comments to firstname.lastname@example.org.
(Last updated: January 28, 2016; last reviewed: January 28, 2016)
The Panel has carefully reviewed results from clinical HIV therapy trials and considered how they affect appropriate care guidelines. HIV care is complex and rapidly evolving. Where possible, the Panel has based recommendations on the best evidence from prospective trials with defined endpoints. Absent such evidence, the Panel has attempted to base recommendations on reasonable options for HIV care.
HIV care requires partnerships and open communication. Guidelines are only a starting point for medical decision making involving informed providers and patients. Although guidelines can identify some parameters of high-quality care, they cannot substitute for sound clinical judgment.
As further research is conducted and reported, these guidelines will be modified. The Panel anticipates continued progress in refining ART regimens and strategies. The Panel hopes these guidelines are useful and is committed to their continued revision and improvement.How to Cite the Guidelines